NCT04797156View on ClinicalTrials.gov

Combined IV and Topical TXA in Major Spine Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Spine SurgeryBack Pain
Interventions
DRUG

High Dose Tranexamic acid

50mg/kg IV TXA

DRUG

Low Dose Tranexamic acid

20mg/kg IV TXA

DRUG

Tranexamic acid Topical

2g topical TXA

DRUG

Normal saline

Normal saline poured on wound

Trial Locations (1)

10019

Mount Sinai West Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04797156 - Combined IV and Topical TXA in Major Spine Surgery | Biotech Hunter | Biotech Hunter